| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 39,622 | 43,449 | 43,373 | 46,136 | | Cost of Revenue | 10,857 | 11,360 | 11,651 | 12,438 | | | Gross Profit |
-
| 32,089 | 31,722 | 33,698 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 22,316 | 23,622 | 21,786 | 23,184 | | Non Recurring | (710) | 445 | 265 | (2,463) | | Others | 20,483 | 6,934 | 8,188 | 12,455 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| 1,088 | 1,483 | 522 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (13,324) | 1,088 | 1,483 | 522 | | Interest Expense | 1,616 | 1,899 | 1,929 | 2,431 | | Income Before Tax | (14,940) | (811) | (446) | (1,909) | | Income Tax Expense | (6,044) | (485) | (592) | (1,064) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (8,896) | (326) | 146 | (845) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (8,896) | (326) | 146 | (845) | | Preferred Stock And Other Adjustments | (464) | (459) | (444) |
-
| | | Net Income Applicable To Common Shares | ($9,360) | ($785) | ($298) | ($845) |
|
0.02% Nasdaq 
0.33%
Income Statement
